Tyche Industries Ltd. | Income Statement

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
1,043
639
541
426
516
539,475
Cost of Goods Sold (COGS) incl. D&A
890
547
464
336
322
329,366
Gross Income
153
91
77
90
194
210,109
SG&A Expense
57
45
64
46
123
136,843
EBIT
93
37
12
44
72
73,266
Non Operating Income/Expense
1
127.70
15
12
17
25,192
Interest Expense
-
11
11
3
1
-
Pretax Income
82
29
26
59
89
98,458
Income Tax
26
9
1
28
30
26,998
Consolidated Net Income
55
19
25
31
59
71,459
Net Income
55
19
25
31
59
71,459
Net Income After Extraordinaries
55
19
25
31
59
71,459
Net Income Available to Common
55
19
25
31
59
71,459
EPS (Basic)
5.40
1.89
2.41
3.01
5.75
6.97
Basic Shares Outstanding
10
10
10
10
-
-
EPS (Diluted)
5.39
1.88
2.41
3.01
-
-
Diluted Shares Outstanding
10
10
10
10
-
-
EBITDA
107
71
29
62
90
91,675
Other Operating Expense
-
4
9
2
-
-
Non-Operating Interest Income
1
3
2
5
-
-

About Tyche Industries

View Profile
Address
H. No. C21/A, Road No. 9
Hyderabad TS 500096
India
Employees -
Website http://www.tycheindustries.com
Updated 07/08/2019
Tyche Industries Ltd. engages in the manufacture of active pharmaceutical ingredient and intermediates. It offers a range of products including Chiral intermediates and nutraceuticals for the treatment of various diseases including diarrhea, emetic, benign prostatic hypertrophy, retroviral, arthritis, inflammatory, microbacteria, and osteoporosis. The company was founded on July 23, 1998 and is headquartered in Hyderabad, India.